Junshi Biosciences: Shareholder Shanghai Tan Ying intends to reduce its stake in the company by no more than 2%

Jinshi Biology announced that its shareholder Shanghai Tianying Fund, holding 6.9602% of the shares, plans to reduce its holding by no more than 20,533,800 shares through block trading from September 5, 2025 to December 4, 2025, which is no more than 2% of the total share capital of the company. The shares in question were all acquired before the IPO.